# The Branded Health Service Medicines (Costs) (Amendment) Regulations 2023, Regulation 2: Amendment of regulation 3 of the Branded Health Service Medicines (Costs) Regulations 2018


(1) Regulation 3 (Payment scheme) of The Branded Health Service Medicines (Costs) Regulations 2018 is amended as follows.
(2) In paragraph (1), for the table substitute—
“Table
Applicable Period
Payment Percentage
1st April 2023 to the end of 2023
27.5%
2024 and any subsequent calendar year
27.5%
”.
(3) In paragraph (1B)—
(a) for “1st July 2022 to the end of 2022” substitute “1st April 2023 to the end of 2023”,
(b) for “17.7%” substitute “28.6%”, and
(c) for “14.3%” substitute “27.5%”.
(4) In paragraph (1C)—
(a) for “1st July 2022 to the end of 2022” substitute “1st April 2023 to the end of 2023”,
(b) in sub-paragraph (a)—
(i) for “1st January 2022” substitute “1st January 2023”, and
(ii) for “30th June 2022” substitute “31st March 2023”, and
(c) in sub-paragraph (b), for “10.9%” substitute “24.4%”.

---
Source: https://www.legislation.gov.uk/uksi/2023/239/regulation/2 (the official version)
Page: https://openlegislation.uk/branded-health-service-medicines-costs-amendment-regulations-2023/regulation-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.